Kurt Jaeckle, MD, Oncology, Jacksonville, FL, Mayo Clinic Hospital in Florida

KurtAlfredJaeckleMD

Oncology Jacksonville, FL

Breast Cancer, Neuro-Oncology

Professor of Neurology and Oncology Consultant Mayo Clinic Florida

Dr. Jaeckle is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jaeckle's full profile

Already have an account?

  • Office

    Mayo Clinic Florida
    4415 Mangurian, 4500 San Pablo Rd
    Jacksonville, FL 32224
    Phone(904) 953-7102
    Fax(904) 525-0757
  • Is this information wrong?

Summary

  • Kurt A. Jaeckle, M.D., is currently Professor of Neurology and Professor of Oncology at the Mayo Clinic Florida in Jacksonville .
    Dr. Jaeckle received his MD from Indiana University School of Medicine, Internship in Medicine and Residency in Neurology at Vanderbilt University in Nashville, TN; and Fellowship in Neuro-oncology at Memorial Sloan Kettering Cancer Center. Dr. Jaeckle is Board Certified in Neurology by the ABPN and in Neuro-oncology by the UCNS. He was an Associate Professor of Neurology at the University of Utah Health Sciences Center; Associate Professor and Deputy Chairman of Neurology at the University of Texas MD Anderson Cancer Center; Medical Director of Research for the Atlantic Health System, and Professor of Neurology and Oncology at the Mayo Clinic.

    Dr. Jaeckle has served as an investigator on several national and international Phase I-III clinical trials, and has authored multiple peer-reviewed papers involving primary and metastatic brain tumors and neurologic complications of cancer. He has served on committees for the American Academy of Neurology, Society for Neurooncology, the National Institutes of Health, and National Cancer Institute. He served as Director of the Neurooncology Fellowship Program at MD Anderson Cancer Center, and was instrumental in development of the Certification and Accreditation in Neurooncology for the UCNS.

    Dr. Jaeckle’s clinical practice and research focuses on targeted treatments, immunotherapy, vaccines, chemotherapy for patients with primary and metastatic CNS neoplasms.

    Dr. Jaeckle enjoys spending time with his wife, Bunny Leach-Jaeckle, supporting her efforts as a patient advocate for ASCO, for the Alliance for Clinical Trials in Oncology, and for Mayo Clinic; and, as Director and CEO of the Nicki Leach Foundation, a non-profit organization supporting cancer research involving adolescents and young adults. He is also a luthier, who builds and repairs acoustic and electric guitars.

Education & Training

  • Memorial Sloan-Kettering Cancer CenterResidency, Neurology, 1981 - 1983
  • Vanderbilt UniversityFellowship, Neuromuscular Medicine, 1980 - 1981
  • Vanderbilt UniversityResidency, Neurology, 1977 - 1981
  • Vanderbilt UniversityInternship, Internal Medicine, 1977 - 1978
  • Indiana University School of MedicineClass of 1977

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2016 - 2019
  • GA State Medical License
    GA State Medical License 2014 - 2021
  • KY State Medical License
    KY State Medical License 2014 - 2017
  • FL State Medical License
    FL State Medical License 2000 - 2022
  • TX State Medical License
    TX State Medical License 1993 - 2002
  • UT State Medical License
    UT State Medical License 1983 - 2004
  • American Board of Psychiatry and Neurology Neurology
  • United Council of Neurologic SubspecialtiesNeuro-oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
    Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage GlioblastomaJanuary 10th, 2018
  • Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits for Patients with Limited Brain Metastases
    Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits for Patients with Limited Brain MetastasesMay 31st, 2015

Professional Memberships

Hospital Affiliations